NuGen Medical Devices Inc. reported that its distribution partner in Mexico, Science-Link Trading SAPI de CV (Science-Link) has expanded their distribution network to now include Argentina, Chile, Costa Rica and Peru. Science-Link is now also partnering with a large family-owned laboratory and clinic conglomerate (Conglomerate Medical) which is expected to see Science-Link expand its operations into big box retail pharmacies in Mexico. Mexico is a large diabetes market globally with an estimated 1 in 6 adults now living with diabetes.

Science-Link is now placing additional orders of InsuJet? for Mexico for 500 units of the Company's needle-free InsuJet? injection device for March 2024 and an order for 1,000 units for April 2024 to begin fulfilling increased demand.

In June 2023 NuGen received its first bulk purchase order from Science-Link for 500 units and consumables of InsuJet?. This order was paid for in full and shipped in November 2023, when InsuJet? received approval from the Mexican Government to be sold as a medical device.

NuGen's agreement with Science-Link targets the sale of approximately 5,000 units and consumables of InSuJet? in 2024. With the expansion of Science-Link to additional countries and its alliance with Conglomerate Medical, NuGen expects to exceed the target of 5,000 needle-free injectors and consumables in 2024 contemplated in its agreement with Science-Link.

The Company estimates a 3 1/2 year lifetime value of $1,350,000 for the sale of the 1,500 units of InsuJet? to Science-Link, the value of the first delivery being $220,000 for first quarter, 2024. The company expects a gross margin of 72%.

Conglomerate Medical is a family-run business with a network of over 150 clinics and 1,500 medical consultants providing diagnostics and medical evaluation services to patients throughout Mexico.